BioRender 图标

Pseudostratified epithelial cell 3

Pseudostratified epithelial cell 3 - Editable icon of Columnar pseudostratified epithelial cell with narrow basal side
[{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fcc13ccf015b9bb371c4/5c0ad66c3fbb901200f2ac2a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fcc13ccf015b9bb371c4/5c0ad66c3fbb901200f2ac2a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fcc13ccf015b9bb371c5/5c0ad66c3fbb901200f2ac2a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fcc13ccf015b9bb371c5/5c0ad66c3fbb901200f2ac2a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fcc13ccf015b9bb371c6/5c0ad66c3fbb901200f2ac2a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fcc13ccf015b9bb371c6/5c0ad66c3fbb901200f2ac2a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fcc13ccf015b9bb371c7/5c0ad66c3fbb901200f2ac2a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fcc13ccf015b9bb371c7/5c0ad66c3fbb901200f2ac2a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fcc13ccf015b9bb371c8/5c0ad66c3fbb901200f2ac2a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fcc13ccf015b9bb371c8/5c0ad66c3fbb901200f2ac2a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fcc13ccf015b9bb371c9/5c0ad66c3fbb901200f2ac2a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fcc13ccf015b9bb371c9/5c0ad66c3fbb901200f2ac2a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fcc13ccf015b9bb371ca/5c0ad66c3fbb901200f2ac2a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fcc13ccf015b9bb371ca/5c0ad66c3fbb901200f2ac2a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fcc13ccf015b9bb371cb/5c0ad66c3fbb901200f2ac2a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fcc13ccf015b9bb371cb/5c0ad66c3fbb901200f2ac2a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fcc13ccf015b9bb371cc/5c0ad66c3fbb901200f2ac2a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fcc13ccf015b9bb371cc/5c0ad66c3fbb901200f2ac2a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fcc13ccf015b9bb371cd/5c0ad66c3fbb901200f2ac2a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fcc13ccf015b9bb371cd/5c0ad66c3fbb901200f2ac2a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fcc13ccf015b9bb371ce/5c0ad66c3fbb901200f2ac2a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fcc13ccf015b9bb371ce/5c0ad66c3fbb901200f2ac2a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fcc13ccf015b9bb371cf/5c0ad66c3fbb901200f2ac2a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fcc13ccf015b9bb371cf/5c0ad66c3fbb901200f2ac2a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fcc13ccf015b9bb371d0/5c0ad66c3fbb901200f2ac2a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fcc13ccf015b9bb371d0/5c0ad66c3fbb901200f2ac2a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fcc13ccf015b9bb371d1/5c0ad66c3fbb901200f2ac2a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fcc13ccf015b9bb371d1/5c0ad66c3fbb901200f2ac2a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fcc13ccf015b9bb371d2/5c0ad66c3fbb901200f2ac2a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fcc13ccf015b9bb371d2/5c0ad66c3fbb901200f2ac2a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fcc13ccf015b9bb371d3/5c0ad66c3fbb901200f2ac2a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fcc13ccf015b9bb371d3/5c0ad66c3fbb901200f2ac2a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fcc13ccf015b9bb371d4/5c0ad66c3fbb901200f2ac2a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fcc13ccf015b9bb371d4/5c0ad66c3fbb901200f2ac2a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fcc13ccf015b9bb371d5/5c0ad66c3fbb901200f2ac2a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fcc13ccf015b9bb371d5/5c0ad66c3fbb901200f2ac2a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fcc13ccf015b9bb371d6/5c0ad66c3fbb901200f2ac2a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fcc13ccf015b9bb371d6/5c0ad66c3fbb901200f2ac2a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fcc13ccf015b9bb371d7/5c0ad66c3fbb901200f2ac2a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fcc13ccf015b9bb371d7/5c0ad66c3fbb901200f2ac2a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fcc13ccf015b9bb371d8/5c0ad66c3fbb901200f2ac2a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fcc13ccf015b9bb371d8/5c0ad66c3fbb901200f2ac2a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fcc13ccf015b9bb371d9/5c0ad66c3fbb901200f2ac2a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fcc13ccf015b9bb371d9/5c0ad66c3fbb901200f2ac2a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fcc13ccf015b9bb371da/5c0ad66c3fbb901200f2ac2a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fcc13ccf015b9bb371da/5c0ad66c3fbb901200f2ac2a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fcc13ccf015b9bb371db/5c0ad66c3fbb901200f2ac2a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fcc13ccf015b9bb371db/5c0ad66c3fbb901200f2ac2a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fcc13ccf015b9bb371dc/5c0ad66c3fbb901200f2ac2a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fcc13ccf015b9bb371dc/5c0ad66c3fbb901200f2ac2a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fcc13ccf015b9bb371dd/5c0ad66c3fbb901200f2ac2a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fcc13ccf015b9bb371dd/5c0ad66c3fbb901200f2ac2a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fcc13ccf015b9bb371de/5c0ad66c3fbb901200f2ac2a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fcc13ccf015b9bb371de/5c0ad66c3fbb901200f2ac2a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fcc13ccf015b9bb371df/5c0ad66c3fbb901200f2ac2a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fcc13ccf015b9bb371df/5c0ad66c3fbb901200f2ac2a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fcc13ccf015b9bb371e0/5c0ad66c3fbb901200f2ac2a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fcc13ccf015b9bb371e0/5c0ad66c3fbb901200f2ac2a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fcc13ccf015b9bb371e1/5c0ad66c3fbb901200f2ac2a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fcc13ccf015b9bb371e1/5c0ad66c3fbb901200f2ac2a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fcc13ccf015b9bb371e2/5c0ad66c3fbb901200f2ac2a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fcc13ccf015b9bb371e2/5c0ad66c3fbb901200f2ac2a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fcc13ccf015b9bb371e3/5c0ad66c3fbb901200f2ac2a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fcc13ccf015b9bb371e3/5c0ad66c3fbb901200f2ac2a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fcc13ccf015b9bb371e4/5c0ad66c3fbb901200f2ac2a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fcc13ccf015b9bb371e4/5c0ad66c3fbb901200f2ac2a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fcc13ccf015b9bb371e5/5c0ad66c3fbb901200f2ac2a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fcc13ccf015b9bb371e5/5c0ad66c3fbb901200f2ac2a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fcc13ccf015b9bb371e6/5c0ad66c3fbb901200f2ac2a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fcc13ccf015b9bb371e6/5c0ad66c3fbb901200f2ac2a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fcc13ccf015b9bb371e7/5c0ad66c3fbb901200f2ac2a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fcc13ccf015b9bb371e7/5c0ad66c3fbb901200f2ac2a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fcc13ccf015b9bb371e8/5c0ad66c3fbb901200f2ac2a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fcc13ccf015b9bb371e8/5c0ad66c3fbb901200f2ac2a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fcc13ccf015b9bb371e9/5c0ad66c3fbb901200f2ac2a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fcc13ccf015b9bb371e9/5c0ad66c3fbb901200f2ac2a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fcc13ccf015b9bb371ea/5c0ad66c3fbb901200f2ac2a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fcc13ccf015b9bb371ea/5c0ad66c3fbb901200f2ac2a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fcc13ccf015b9bb371eb/5c0ad66c3fbb901200f2ac2a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fcc13ccf015b9bb371eb/5c0ad66c3fbb901200f2ac2a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fcc13ccf015b9bb371ec/5c0ad66c3fbb901200f2ac2a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fcc13ccf015b9bb371ec/5c0ad66c3fbb901200f2ac2a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fcc13ccf015b9bb371ed/5c0ad66c3fbb901200f2ac2a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fcc13ccf015b9bb371ed/5c0ad66c3fbb901200f2ac2a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fcc13ccf015b9bb371ee/5c0ad66c3fbb901200f2ac2a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fcc13ccf015b9bb371ee/5c0ad66c3fbb901200f2ac2a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fcc13ccf015b9bb371ef/5c0ad66c3fbb901200f2ac2a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fcc13ccf015b9bb371ef/5c0ad66c3fbb901200f2ac2a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fcc13ccf015b9bb371f0/5c0ad66c3fbb901200f2ac2a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fcc13ccf015b9bb371f0/5c0ad66c3fbb901200f2ac2a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fcc13ccf015b9bb371f1/5c0ad66c3fbb901200f2ac2a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fcc13ccf015b9bb371f1/5c0ad66c3fbb901200f2ac2a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fcc13ccf015b9bb371f2/5c0ad66c3fbb901200f2ac2a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fcc13ccf015b9bb371f2/5c0ad66c3fbb901200f2ac2a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fcc13ccf015b9bb371f3/5c0ad66c3fbb901200f2ac2a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fcc13ccf015b9bb371f3/5c0ad66c3fbb901200f2ac2a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fcc13ccf015b9bb371f4/5c0ad66c3fbb901200f2ac2a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fcc13ccf015b9bb371f4/5c0ad66c3fbb901200f2ac2a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fcc13ccf015b9bb371f5/5c0ad66c3fbb901200f2ac2a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fcc13ccf015b9bb371f5/5c0ad66c3fbb901200f2ac2a.png"}]
使用此图标 – 免费
注册无需信用卡。

此图标可在 BioRender 中完全编辑

  • 添加文本、形状及其他图标
  • 搜索 50,000 多种科学准确的图标
  • 重新着色并重新排列每一个图标、线条和标签
  • 导出或分享以满足任何使用需求
Scientist Avatars

加入 400 多万名科学家 的行列,制作可直接用于发表的图表

从图标到成品图表,只需几分钟

  • 搜索 来自 50,000 多个科学准确、经同行评审的图标
  • 自定义 添加标签、形状和更多图标——一切皆可完全编辑
  • 导出 或与协作者分享您的图表
    ‍

图标不合适?探索更多内容。

搜索涵盖 30 多个生命科学领域的 50,000 多个图标。

search icon
arrow-right
epithelium,columnar,epithelia,pseudostratified epithelium,pseudostratified epithelial cell
查看更多

尝试使用同义词,或注册以在应用中请求图标。

图像类型

Pseudostratified epithelial cell 3 icon JPEG

Pseudostratified epithelial cell 3 icon PNG

Pseudostratified epithelial cell 3 icon SVG

Pseudostratified epithelial cell 3 icon GIF

BioRender 图标常见问题解答

How are scientists using the Pseudostratified epithelial cell 3 icon in their work?

BioRender users often use the Pseudostratified epithelial cell 3 icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Cell Types.

我可以在 BioRender 图表或科学插图中使用此图标吗?

Yes, the Pseudostratified epithelial cell 3 is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.

Is the Pseudostratified epithelial cell 3 icon customizable in BioRender?

Most icons in BioRender, including the Pseudostratified epithelial cell 3 icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.

Can I export figures that include the Pseudostratified epithelial cell 3 icon for publication or presentations?

Yes, figures containing the Pseudostratified epithelial cell 3 icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

How do I cite BioRender if I use this icon?

Unlock publication permissions with a paid plan, and include 'Created with BioRender.com' in your figure legend, or cite BioRender directly per your journal's guidelines.

Is the Pseudostratified epithelial cell 3 icon used in BioRender templates or poster layouts?

Many BioRender templates include icons like the Pseudostratified epithelial cell 3 icon — especially those focused on Cell Types. You can search BioRender’s template library or add this icon manually to any canvas.

什么是 BioRender?

BioRender is a web‑based software that helps you create scientific figures in minutes. Use this Pseudostratified epithelial cell 3 icon along with our library of more than 30,000 life science icons.

在 BioRender 中使用此图标

立即开始制作专业的科学图表
antibody elements3D Phospholipid illustration

正在寻找科学内容?

浏览超过 5 万个经同行评审、易于使用且免费的图标和模板。

立即寻找您的专属素材
x icon